Medico Intercontinental Management

Management Kriterienprüfungen 2/4

Medico Intercontinental CEO ist Dilipkumar Shah , ernannt in May 2019, hat eine Amtszeit von 5.5 Jahren. besitzt direkt 10.74% der Aktien des Unternehmens, im Wert von ₹65.85M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.4 Jahre bzw. 5.6 Jahre.

Wichtige Informationen

Dilipkumar Shah

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	5.5yrs
Eigentum des Geschäftsführers	10.7%
Durchschnittliche Amtszeit des Managements	5.4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	5.6yrs

Jüngste Management Updates

Recent updates

Geschäftsführer

Dilipkumar Shah

5.5yrs

Amtszeit

Mr. Dilipkumar Bhogilal Shah has been Chief Executive Officer of Medico Intercontinental Limited since May 29, 2019. Mr. Shah has vast experience of more than 40 years in Pharma Business.

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Samir Shah	MD & Director	no data	₹6.00m	44.33% ₹ 271.7m
Dilipkumar Shah	Chief Executive Officer	5.5yrs	keine Daten	10.74% ₹ 65.8m
Jay Shah	Chief Financial Officer	5.3yrs	₹719.65k	keine Daten
Puneeta Sharma	Company Secretary & Compliance Officer	5.4yrs	₹438.19k	keine Daten

5.4yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrenes Management: 539938Das Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (5.4 ).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Samir Shah	MD & Director	6.3yrs	₹6.00m	44.33% ₹ 271.7m
Tanvi Shah	Non-Executive Chairman	6.3yrs	keine Daten	keine Daten
Ankur Dave	Independent Director	5.7yrs	keine Daten	keine Daten
Swati Shah	Non-Executive Director	5.5yrs	keine Daten	keine Daten
Priyank Sancheti	Independent Director	2yrs	keine Daten	keine Daten
Parshwa Shah	Independent Director	less than a year	keine Daten	keine Daten

5.6yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrener Vorstand: 539938Die Vorstandsmitglieder gelten als erfahren (5.6 Jahre durchschnittliche Amtszeit).

Medico Intercontinental Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

Medico Intercontinental Limited, Annual General Meeting, Sep 27, 2024

Less than half of directors are independent

Medico Intercontinental Limited Announces Resignation of Nikul Dipakbhai Shah as Independent Director

MD & Director recently bought ₹926k worth of stock

Medico Intercontinental Limited, Annual General Meeting, Jun 30, 2023

Medico Intercontinental Limited Appoints Priyank L Sancheti as an Additional Independent Director

Recent updates

Second quarter 2025 earnings released: EPS: ₹1.63 (vs ₹0.87 in 2Q 2024)

Investor sentiment improves as stock rises 23%

Medico Intercontinental Limited to Report Q2, 2025 Results on Nov 14, 2024

Investor sentiment deteriorates as stock falls 17%

First quarter 2025 earnings released: EPS: ₹1.08 (vs ₹0.94 in 1Q 2024)

Medico Intercontinental Limited, Annual General Meeting, Sep 27, 2024

Medico Intercontinental Limited to Report Q1, 2025 Results on Aug 13, 2024

Medico Intercontinental Limited to Report Q1, 2025 Results on Aug 13, 2024

Investor sentiment improves as stock rises 17%

Medico Intercontinental Limited to Report Q4, 2024 Results on May 25, 2024

Less than half of directors are independent

Medico Intercontinental Limited Announces Resignation of Nikul Dipakbhai Shah as Independent Director

Investor sentiment improves as stock rises 22%

Investor sentiment deteriorates as stock falls 15%

New major risk - Market cap size

Third quarter 2024 earnings released: EPS: ₹1.02 (vs ₹0.94 in 3Q 2023)

Investor sentiment deteriorates as stock falls 17%

Medico Intercontinental Limited to Report Q3, 2024 Results on Feb 14, 2024

Investor sentiment improves as stock rises 16%

MD & Director recently bought ₹926k worth of stock

Second quarter 2024 earnings released: EPS: ₹0.87 (vs ₹2.66 in 2Q 2023)

Medico Intercontinental Limited to Report Q1, 2024 Results on Aug 14, 2023

Medico Intercontinental Limited Approves Final Equity Dividend for the Financial Year 2022-23

Full year 2023 earnings released: EPS: ₹5.61 (vs ₹9.54 in FY 2022)

Medico Intercontinental Limited, Annual General Meeting, Jun 30, 2023

Medico Intercontinental Limited to Report Q4, 2023 Results on May 29, 2023

Investor sentiment improves as stock rises 25%

Third quarter 2023 earnings released: EPS: ₹0.94 (vs ₹2.30 in 3Q 2022)

Investor sentiment improves as stock rises 25%

Medico Intercontinental Limited to Report Q3, 2023 Results on Feb 14, 2023

Second quarter 2023 earnings released: EPS: ₹2.66 (vs ₹2.29 in 2Q 2022)

Medico Intercontinental Limited Appoints Priyank L Sancheti as an Additional Independent Director

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Medico Intercontinental Limited Approves Regularisation of Nikul Dipakbhai Shah as an Independent Director

Investor sentiment improved over the past week

Medico Intercontinental Limited announced that it expects to receive INR 249.787 million in funding

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Medico Intercontinental Limited to Report Q4, 2022 Results on May 28, 2022

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Less than half of directors are independent

Medico Intercontinental Limited Announces Resignation Mr. Hiren Ravindrabhai Shah as Independent Director

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

High number of new directors

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹7.93 (vs ₹7.25 in FY 2020)

Investor sentiment improved over the past week

New 90-day low: ₹35.00

Medico Intercontinental Limited to Report Nine Months, 2021 Results on Feb 12, 2021

New 90-day high: ₹54.35

Market bids up stock over the past week

New 90-day low: ₹28.00

Market pulls back on stock over the past week

Market pulls back on stock over the past week

First quarter earnings released

New 90-day high - ₹48.75

Medico Intercontinental Limited to Report Q1, 2021 Results on Sep 15, 2020

New 90-day high - ₹32.80

Medico Intercontinental Limited announced that it expects to receive INR 52.32025 million in funding

Medico Intercontinental Limited to Report Q4, 2020 Results on Jun 30, 2020

Geschäftsführer

Amtszeit